EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,243,983 | +11.8% | 377,299 | -2.2% | 0.01% | +25.0% |
Q2 2023 | $7,373,116 | -2.5% | 385,825 | -0.9% | 0.00% | 0.0% |
Q1 2023 | $7,558,487 | +19.0% | 389,412 | -2.4% | 0.00% | 0.0% |
Q4 2022 | $6,350,252 | -1.1% | 399,175 | -2.2% | 0.00% | 0.0% |
Q3 2022 | $6,421,728 | -28.7% | 408,050 | -5.7% | 0.00% | -33.3% |
Q2 2022 | $9,002,672 | -12.0% | 432,641 | -4.6% | 0.01% | -14.3% |
Q1 2022 | $10,233,080 | +55.6% | 453,283 | +26.9% | 0.01% | +75.0% |
Q4 2021 | $6,575,000 | -14.3% | 357,226 | -1.5% | 0.00% | -33.3% |
Q3 2021 | $7,669,000 | +22.7% | 362,751 | +5.7% | 0.01% | +20.0% |
Q2 2021 | $6,252,000 | -20.9% | 343,132 | -2.0% | 0.01% | -28.6% |
Q1 2021 | $7,907,000 | +5.5% | 350,031 | -6.3% | 0.01% | 0.0% |
Q4 2020 | $7,495,000 | -24.3% | 373,434 | -7.8% | 0.01% | -30.0% |
Q3 2020 | $9,902,000 | +6.0% | 404,971 | -1.5% | 0.01% | +11.1% |
Q2 2020 | $9,344,000 | +24.7% | 411,074 | -5.5% | 0.01% | +12.5% |
Q1 2020 | $7,494,000 | -0.3% | 435,220 | +2.1% | 0.01% | 0.0% |
Q4 2019 | $7,514,000 | -7.1% | 426,433 | -5.1% | 0.01% | -11.1% |
Q3 2019 | $8,090,000 | -23.0% | 449,568 | -8.6% | 0.01% | -25.0% |
Q2 2019 | $10,510,000 | -9.8% | 491,829 | +0.4% | 0.01% | -7.7% |
Q1 2019 | $11,654,000 | +17.7% | 489,678 | -2.7% | 0.01% | +8.3% |
Q4 2018 | $9,901,000 | +13.1% | 503,384 | +1.9% | 0.01% | +33.3% |
Q3 2018 | $8,751,000 | -7.2% | 493,816 | +12.7% | 0.01% | -10.0% |
Q2 2018 | $9,429,000 | +4942.2% | 438,173 | +5082.4% | 0.01% | – |
Q1 2018 | $187,000 | -30.2% | 8,455 | -4.1% | 0.00% | – |
Q4 2017 | $268,000 | +22.9% | 8,820 | -2.1% | 0.00% | – |
Q3 2017 | $218,000 | -1.8% | 9,009 | +0.1% | 0.00% | – |
Q2 2017 | $222,000 | -94.2% | 9,004 | -94.9% | 0.00% | -100.0% |
Q1 2017 | $3,836,000 | +66.6% | 177,041 | +14.6% | 0.01% | +66.7% |
Q4 2016 | $2,303,000 | +16.4% | 154,494 | -0.1% | 0.00% | 0.0% |
Q3 2016 | $1,979,000 | +63.8% | 154,719 | +0.0% | 0.00% | +50.0% |
Q2 2016 | $1,208,000 | +105.4% | 154,665 | +2.5% | 0.00% | +100.0% |
Q1 2016 | $588,000 | -28.6% | 150,938 | +3.3% | 0.00% | 0.0% |
Q4 2015 | $824,000 | +1.5% | 146,172 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $812,000 | +71.7% | 144,725 | +15.2% | 0.00% | 0.0% |
Q2 2015 | $473,000 | +39.1% | 125,671 | -4.9% | 0.00% | – |
Q1 2015 | $340,000 | +77.1% | 132,123 | -1.1% | 0.00% | – |
Q4 2014 | $192,000 | -1.5% | 133,623 | +4.7% | 0.00% | – |
Q3 2014 | $195,000 | -53.9% | 127,636 | +2.2% | 0.00% | -100.0% |
Q2 2014 | $423,000 | -18.0% | 124,859 | -14.5% | 0.00% | 0.0% |
Q1 2014 | $516,000 | -40.2% | 145,991 | +3.8% | 0.00% | 0.0% |
Q4 2013 | $863,000 | +5.0% | 140,701 | -0.3% | 0.00% | 0.0% |
Q3 2013 | $822,000 | +24.9% | 141,089 | -2.7% | 0.00% | 0.0% |
Q2 2013 | $658,000 | – | 145,012 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |